Stock BSPM BIOSTAR PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Biostar Pharmaceuticals, Inc.

Equities

BSPM

US0906783016

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 15:42:37 2024-04-23 EDT 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Biostar Pharmaceuticals, Inc. -.--% -.--%
2023 Biostar Pharmaceuticals, Inc. Announces FDA Approval of Utidelone Injectable Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer CI
2023 Biostar Pharma, Inc. Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule CI

Business Summary

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The Company offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The Company's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The Company's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.

Number of employees: 200

Sales per Business

USD in Million2015Weight2016Weight Delta
Pharmaceutical Products
100.0 %
27 100.0 % 2 100.0 % -91.21%

Sales per region

USD in Million2015Weight2016Weight Delta
China
100.0 %
27 100.0 % 2 100.0 % -91.21%

Managers

Managers TitleAgeSince
Rong Hua Wang CEO
 Chief Executive Officer 69 07-03-26
Xiaojuan Zhai DFI
 Director of Finance/CFO - 17-02-04
Zheng Hong Wang COO
 Chief Operating Officer 43 12-02-29
Gong Shuang ADM
 Chief Administrative Officer 54 06-12-31

Members of the board

Members of the board TitleAgeSince
Rong Hua Wang CEO
 Chief Executive Officer 69 07-03-26
Hai Peng Wu BRD
 Director/Board Member 66 07-06-30
Zhan Xiang Ma BRD
 Director/Board Member - 18-01-28
Hui ping Liao BRD
 Director/Board Member - 18-01-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,637,188 2,637,188 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
RENN Capital Group, Inc.
0.4333 %
11,426 0.4333 % - $

Company contact information

BioStar Pharmaceuticals, Inc.

No. 588 Shiji Xi Avenue

712046, Xianyang

+86 29 3368 6638

address Biostar Pharmaceuticals, Inc.(BSPM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
BIOSTAR PHARMACEUTICALS, INC. Stock Biostar Pharmaceuticals, Inc.
-.--% 263
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.59% 727B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.89% 347B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.66% 319B
ABBVIE INC. Stock AbbVie Inc.
+0.24% 274B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.98% 238B
NOVARTIS AG Stock Novartis AG
+6.99% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-6.46% 203B
AMGEN INC. Stock Amgen Inc.
+4.23% 161B
PFIZER, INC. Stock Pfizer, Inc.
-1.70% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BSPM Stock
  4. Company Biostar Pharmaceuticals, Inc.